Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP404114.RAHhVDavxnHE4OcNtR6ODKIgwcnZzBF24ijWswnNldMrM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP404114.RAHhVDavxnHE4OcNtR6ODKIgwcnZzBF24ijWswnNldMrM130_assertion type Assertion NP404114.RAHhVDavxnHE4OcNtR6ODKIgwcnZzBF24ijWswnNldMrM130_head.
- NP404114.RAHhVDavxnHE4OcNtR6ODKIgwcnZzBF24ijWswnNldMrM130_assertion description "[Based on a total of 5,628 cases and 3,514 controls from JHH, CGEMS, and CAPS, men who carry any combination of 1, 2, 3, and 4 or more of these five risk variants have an estimated OR (95% CI) of 1.41 (1.20-1.67), 1.88 (1.59-2.22), 2.36 (1.95-2.85), and 3.80 (2.77-5.22) for prostate cancer, respectively, compared to men who do not have any of these five risk variants.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP404114.RAHhVDavxnHE4OcNtR6ODKIgwcnZzBF24ijWswnNldMrM130_provenance.
- NP404114.RAHhVDavxnHE4OcNtR6ODKIgwcnZzBF24ijWswnNldMrM130_assertion evidence source_evidence_literature NP404114.RAHhVDavxnHE4OcNtR6ODKIgwcnZzBF24ijWswnNldMrM130_provenance.
- NP404114.RAHhVDavxnHE4OcNtR6ODKIgwcnZzBF24ijWswnNldMrM130_assertion SIO_000772 18491292 NP404114.RAHhVDavxnHE4OcNtR6ODKIgwcnZzBF24ijWswnNldMrM130_provenance.
- NP404114.RAHhVDavxnHE4OcNtR6ODKIgwcnZzBF24ijWswnNldMrM130_assertion wasDerivedFrom befree-20140225 NP404114.RAHhVDavxnHE4OcNtR6ODKIgwcnZzBF24ijWswnNldMrM130_provenance.
- NP404114.RAHhVDavxnHE4OcNtR6ODKIgwcnZzBF24ijWswnNldMrM130_assertion wasGeneratedBy ECO_0000203 NP404114.RAHhVDavxnHE4OcNtR6ODKIgwcnZzBF24ijWswnNldMrM130_provenance.